General Information of Drug (ID: DME6OXB)

Drug Name
AKL-0707 Drug Info
Synonyms Akela GHRH; LAB GHRH; GHRH analog, Akela; Malnutrition therapy, LAB International
Indication
Disease Entry ICD 11 Status REF
Lipodystrophy EF01 Discontinued in Phase 2 [1]
Cross-matching ID
TTD Drug ID
DME6OXB

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sermorelin DM25HP1 Pediatric growth disorder FB86 Approved [3]
Tesamorelin DM9GP85 HIV-associated lipodystrophy 1C62.1 Approved [4]
Examorelin DMGJMQH Growth hormone deficiency 5A61.3 Discontinued in Phase 2 [5]
L-692429 DMLHE5A Growth hormone deficiency 5A61.3 Discontinued in Phase 1 [6]
NNC-26-0762 DMLTYFI Growth hormone deficiency 5A61.3 Terminated [7]
Mutated growth hormone DMAY50R Acromegaly 5A60.0 Investigative [8]
⏷ Show the Full List of 6 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Growth hormone-releasing hormone receptor (GHRHR) TTG4R8V GHRHR_HUMAN Agonist [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021539)
2 A super-agonist of growth hormone-releasing hormone causes rapid improvement of nutritional status in patients with chronic kidney disease. Kidney Int. 2010 Mar;77(5):450-8.
3 Sermorelin: a better approach to management of adult-onset growth hormone insufficiency Clin Interv Aging. 2006;1(4):307-8.
4 Mullard A: 2010 FDA drug approvals. Nat Rev Drug Discov. 2011 Feb;10(2):82-5.
5 Hexarelin is a stronger GH-releasing peptide than GHRH in normal cycling women but not in anorexia nervosa. J Endocrinol Invest. 1997 May;20(5):257-63.
6 Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrel... Mol Endocrinol. 2005 Sep;19(9):2400-11.
7 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010046)
8 Treatment strategies for acromegaly. Expert Opin Emerg Drugs. 2005 Nov;10(4):875-90.